A recombinant commensal bacteria elicits heterologous antigen-specific immune responses during pharyngeal carriage
A recombinant commensal bacteria elicits heterologous antigen-specific immune responses during pharyngeal carriage
The human nasopharynx contains a stable microbial ecosystem of commensal and potentially pathogenic bacteria, which can elicit protective primary and secondary immune responses. Experimental intranasal infection of human adults with the commensal Neisseria lactamica produced safe, sustained pharyngeal colonization. This has potential utility as a vehicle for sustained release of antigen to the human mucosa, but commensals in general are thought to be immunologically tolerated. Here, we show that engineered N. lactamica, chromosomally transformed to express a heterologous vaccine antigen, safely induces systemic, antigen-specific immune responses during carriage in humans. When the N. lactamica expressing the meningococcal antigen Neisseria Adhesin A (NadA) was inoculated intranasally into human volunteers, all colonized participants carried the bacteria asymptomatically for at least 28 days, with most (86%) still carrying the bacteria at 90 days. Compared to an otherwise isogenic but phenotypically wild-type strain, colonization with NadA-expressing N. lactamica generated NadA-specific immunoglobulin G (IgG)- and IgA-secreting plasma cells within 14 days of colonization and NadA-specific IgG memory B cells within 28 days of colonization. NadA-specific IgG memory B cells were detected in peripheral blood of colonized participants for at least 90 days. Over the same period, there was seroconversion against NadA and generation of serum bactericidal antibody activity against a NadA-expressing meningococcus. The controlled infection was safe, and there was no transmission to adult bedroom sharers during the 90-day period. Genetically modified N. lactamica could therefore be used to generate beneficial immune responses to heterologous antigens during sustained pharyngeal carriage.
Laver, Jay R
b2996398-2ccf-40f0-92b8-f338f3de796b
Gbesemete, Diane
45c5ae20-20f8-4bc0-b3cd-c9a102e94471
Dale, Adam P
5096a630-1d0b-4e37-a1d4-e971e08acb54
Pounce, Zoe C
1a5f95d6-c7a5-4787-89be-269d1c1e863a
Webb, Carl N
1abacc63-74d1-41a1-a5c3-6ba049a1f901
Roche, Eleanor F
ef1fe7fd-fd1c-43fc-bfe8-fbe9117c198e
Berreen, Graham
9e0e2e7b-e3c8-4c54-a083-fa79c107cf3c
Belogiannis, Konstantinos
11dc0860-0867-4d2b-bd9f-8fca9093042e
Hill, Alison R
c22f3bbd-0eab-4a2c-a3cd-7ee495dfd49e
Ibrahim, Muktar M
92069adb-ce7d-4cb1-9491-c1c68bb5be19
Cleary, David W
f4079c6d-d54b-4108-b346-b0069035bec0
Pandey, Anish K
bfb6596d-f222-481c-a594-329a8cc87043
Humphries, Holly E
dfbfbf86-71b7-4a11-8192-0afd0eb817a6
Allen, Lauren
b485b2fa-0353-44ae-801c-1603835ab5a5
Graaf, Hans de
447e78ed-346f-45bb-9238-fce2118d5559
Maiden, Martin C
721886a4-7548-45c8-882f-7a9cae695c0c
Faust, Saul N
f97df780-9f9b-418e-b349-7adf63e150c1
Gorringe, Andrew R
00257a3d-0c2b-479b-ab37-c7b7f65445a3
Read, Robert C
b5caca7b-0063-438a-b703-7ecbb6fc2b51
7 July 2021
Laver, Jay R
b2996398-2ccf-40f0-92b8-f338f3de796b
Gbesemete, Diane
45c5ae20-20f8-4bc0-b3cd-c9a102e94471
Dale, Adam P
5096a630-1d0b-4e37-a1d4-e971e08acb54
Pounce, Zoe C
1a5f95d6-c7a5-4787-89be-269d1c1e863a
Webb, Carl N
1abacc63-74d1-41a1-a5c3-6ba049a1f901
Roche, Eleanor F
ef1fe7fd-fd1c-43fc-bfe8-fbe9117c198e
Berreen, Graham
9e0e2e7b-e3c8-4c54-a083-fa79c107cf3c
Belogiannis, Konstantinos
11dc0860-0867-4d2b-bd9f-8fca9093042e
Hill, Alison R
c22f3bbd-0eab-4a2c-a3cd-7ee495dfd49e
Ibrahim, Muktar M
92069adb-ce7d-4cb1-9491-c1c68bb5be19
Cleary, David W
f4079c6d-d54b-4108-b346-b0069035bec0
Pandey, Anish K
bfb6596d-f222-481c-a594-329a8cc87043
Humphries, Holly E
dfbfbf86-71b7-4a11-8192-0afd0eb817a6
Allen, Lauren
b485b2fa-0353-44ae-801c-1603835ab5a5
Graaf, Hans de
447e78ed-346f-45bb-9238-fce2118d5559
Maiden, Martin C
721886a4-7548-45c8-882f-7a9cae695c0c
Faust, Saul N
f97df780-9f9b-418e-b349-7adf63e150c1
Gorringe, Andrew R
00257a3d-0c2b-479b-ab37-c7b7f65445a3
Read, Robert C
b5caca7b-0063-438a-b703-7ecbb6fc2b51
Laver, Jay R, Gbesemete, Diane, Dale, Adam P, Pounce, Zoe C, Webb, Carl N, Roche, Eleanor F, Berreen, Graham, Belogiannis, Konstantinos, Hill, Alison R, Ibrahim, Muktar M, Cleary, David W, Pandey, Anish K, Humphries, Holly E, Allen, Lauren, Graaf, Hans de, Maiden, Martin C, Faust, Saul N, Gorringe, Andrew R and Read, Robert C
(2021)
A recombinant commensal bacteria elicits heterologous antigen-specific immune responses during pharyngeal carriage.
Science Translational Medicine, 13 (601), [eabe8573].
(doi:10.1126/scitranslmed.abe8573).
Abstract
The human nasopharynx contains a stable microbial ecosystem of commensal and potentially pathogenic bacteria, which can elicit protective primary and secondary immune responses. Experimental intranasal infection of human adults with the commensal Neisseria lactamica produced safe, sustained pharyngeal colonization. This has potential utility as a vehicle for sustained release of antigen to the human mucosa, but commensals in general are thought to be immunologically tolerated. Here, we show that engineered N. lactamica, chromosomally transformed to express a heterologous vaccine antigen, safely induces systemic, antigen-specific immune responses during carriage in humans. When the N. lactamica expressing the meningococcal antigen Neisseria Adhesin A (NadA) was inoculated intranasally into human volunteers, all colonized participants carried the bacteria asymptomatically for at least 28 days, with most (86%) still carrying the bacteria at 90 days. Compared to an otherwise isogenic but phenotypically wild-type strain, colonization with NadA-expressing N. lactamica generated NadA-specific immunoglobulin G (IgG)- and IgA-secreting plasma cells within 14 days of colonization and NadA-specific IgG memory B cells within 28 days of colonization. NadA-specific IgG memory B cells were detected in peripheral blood of colonized participants for at least 90 days. Over the same period, there was seroconversion against NadA and generation of serum bactericidal antibody activity against a NadA-expressing meningococcus. The controlled infection was safe, and there was no transmission to adult bedroom sharers during the 90-day period. Genetically modified N. lactamica could therefore be used to generate beneficial immune responses to heterologous antigens during sustained pharyngeal carriage.
Text
2020.05.06.20093450v1.full (1)
- Author's Original
Text
abe8573 - Accepted Manuscript
- Accepted Manuscript
More information
Accepted/In Press date: 25 May 2021
Published date: 7 July 2021
Additional Information:
Publisher Copyright:
© 2021 American Association for the Advancement of Science. All rights reserved.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
Identifiers
Local EPrints ID: 450488
URI: http://eprints.soton.ac.uk/id/eprint/450488
ISSN: 1946-6234
PURE UUID: 3f72581c-e8bb-4413-a805-31d8f35fded3
Catalogue record
Date deposited: 30 Jul 2021 16:30
Last modified: 06 Jun 2024 01:59
Export record
Altmetrics
Contributors
Author:
Diane Gbesemete
Author:
Adam P Dale
Author:
Zoe C Pounce
Author:
Carl N Webb
Author:
Eleanor F Roche
Author:
Graham Berreen
Author:
Konstantinos Belogiannis
Author:
Alison R Hill
Author:
Muktar M Ibrahim
Author:
Anish K Pandey
Author:
Holly E Humphries
Author:
Lauren Allen
Author:
Hans de Graaf
Author:
Martin C Maiden
Author:
Andrew R Gorringe
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics